U.S. Bioscience Suspends Test of AIDS Drug Lodenosine CDC Daily UpdateImportant note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




U.S. Bioscience Suspends Test of AIDS Drug Lodenosine

Wall Street Journal (10/15/99) P. B2
Winslow, Ron


Just three weeks after agreeing to be acquired by MedImmune, U.S. Bioscience Thursday said it halted clinical trials of its AIDS drug lodenosine because one patient died and others exhibited signs of potential liver or kidney damage. Company officials noted that all patients in the trial have stopped using lodenosine and were still taking other drugs used in the trial, including Merck's Crixivan and Bristol-Myers Squibb's Zerit. The company indicated that the problems were discovered after positive preliminary results were reported at a meeting in San Francisco last month. U.S. Bioscience plans to review the data and work with the Food and Drug Administration to decide on a future course of action, which could include indefinitely suspending the testing.


991015
AD991747


Copyright © 1999 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.